Clinical Trials
For More Information, email us at ClinicalTrials@espmgmt.com
Current Clinical Trials
The clinical trials introduce new technology and medication to patients with a variety of conditions.
- Presbyopia
- Dry Eye
- Advanced Macular Degeneration
- Cataracts
- Diabetic Retinopathy
These clinical trials are a crucial component in developing new, more effective, sight-saving and sight-prolonging diagnostic techniques and treatments. Many of today’s gold-standard therapies are based on the results of previous trials, such as those we’ve conducted for the treatment of macular degeneration, glaucoma, cataracts, and other conditions.
Participation in a clinical trial is completely voluntary. Criteria for study participation is very stringent, and some people may not be eligible for participation. Limited number of participants are needed.
Why Participate In A Study
Millions of Americans suffer with vision impairment, among the most common disabilities in the U.S. Clinical research is an avenue for receiving promising new therapies that may not otherwise be available.
- Access to New Treatments
- Close Monitoring and Care
- Financial Benefits
- Current Treatment or Medication Is Not Satisfactory
- Insurance Limitations on Treatment Options Or Medications
Benefits To Participants
All clinical trials have guidelines about who can participate. These criteria guidelines are based on such factors as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. Before joining a clinical trial, a participant must qualify for the study. Participant benefits vary by study.
- Exam(s) by physician
- Testing
- Lab work
- Frequent check-ups
- Medications
- Reimbursement for time and travel (may be available)
